Your search returned 2 results.

Results
	1.	Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab. [electronic resource] by Sfikakis, Petros P Markomichelakis, Nikos Theodossiadis, George P Grigoropoulos, Vlassis Katsilambros, Nikos Theodossiadis, Panayiotis G Producer: 20050531 In: Diabetes care vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study. [electronic resource] by Sfikakis, Petros P Grigoropoulos, Vlassis Emfietzoglou, Ioannis Theodossiadis, George Tentolouris, Nicholas Delicha, Evi Katsiari, Christina Alexiadou, Kleopatra Hatziagelaki, Erifili Theodossiadis, Panayiotis G Producer: 20101021 In: Diabetes care vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search